Sequential treatments in hereditary leiomyomatosis and renal cell carcinoma (HLRCC): Case report and review of the literature

by de Velasco, Guillermo, Munoz, Cesar, Sepulveda, Juan M., Castellano, Daniel
Published in Can Urol Assoc J (2015)

Three case reports: Temporal association between tyrosine-kinase inhibitor-induced hepatitis and immune checkpoint inhibitors in renal cell carcinoma

by Carretero-González, Alberto, Salamanca Santamaría, Javier, Castellano, Daniel, de Velasco, Guillermo
Published in Medicine (Baltimore) (2019)

Efficacy and safety of anti-PD-1/PD-L1 combinations versus standard of care in cancer: a systematic review and meta-analysis.

by Carretero-González, Alberto, Otero, Irene, Lora, David, Carril-Ajuria, Lucía, Castellano, Daniel, de Velasco, Guillermo
Published in Oncoimmunology (2021)

The Role of RANK-Ligand Inhibition in Cancer: The Story of Denosumab

by Castellano, Daniel, Sepulveda, Juan Manuel, García-Escobar, Ignacio, Rodriguez-Antolín, Alfredo, Sundlöv, Anna, Cortes-Funes, Hernán
Published 2011

Comparative safety analysis of immunotherapy combined with chemotherapy versus monotherapy in solid tumors: a meta-analysis of randomized clinical trials

by Carretero-González, Alberto, Lora, David, Ghanem, Ismael, Otero, Irene, López, Flora, Castellano, Daniel, de Velasco, Guillermo
Published in Oncotarget (2019)

Everolimus Plus Octreotide Long-Acting Repeatable in Patients With Colorectal Neuroendocrine Tumors: A Subgroup Analysis of the Phase III RADIANT-2 Study

by Castellano, Daniel, Bajetta, Emilio, Panneerselvam, Ashok, Saletan, Stephen, Kocha, Walter, O'Dorisio, Thomas, Anthony, Lowell B., Hobday, Timothy
Published 2013

Controversies in the treatment of invasive urothelial carcinoma: a case report and review of the literature

by Guillem, Vicente, Climent, Miguel Angel, Cassinello, Javier, Esteban, Emilio, Castellano, Daniel, González-Larriba, José Luis, Maroto, Pablo, Camps, Carlos
Published in BMC Urol (2015)

Well-Differentiated Grade 2, Type 3 Gastrointestinal Neuroendocrine Tumour with Bilateral Metastatic Ovarian Involvement: Report of an Unusual Case

by Manneh, Ray, Castellano, Daniel, Caso, Oscar, Loinaz, Carmelo, Jiménez, Jesús, Estenoz, Juana, Calatayud, Maria, Sepúlveda, Juan M., García-Carbonero, Rocio
Published in Case Rep Oncol (2016)

Brain perfusion and permeability in patients with advanced, refractory glioblastoma treated with lomustine and the transforming growth factor-β receptor I kinase inhibitor LY215729...

by SEPULVEDA-SANCHEZ, JUAN, RAMOS, ANA, HILARIO, AMAYA, DE VELASCO, GUILLERMO, CASTELLANO, DANIEL, GARCIA DE LA TORRE, MARTA, RODON, JORDI, LAHN, MICHAEL F.
Published in Oncol Lett (2015)

Safety and effectiveness of vinflunine in patients with metastatic transitional cell carcinoma of the urothelial tract after failure of one platinum-based systemic therapy in clini...

by Castellano, Daniel, Puente, Javier, de Velasco, Guillermo, Chirivella, Isabel, López-Criado, Pilar, Mohedano, Nicolás, Fernández, Ovidio, García-Carbonero, Icíar, González, María Belén, Grande, Enrique
Published 2014

Analysis of response rate with ANTI PD1/PD-L1 monoclonal antibodies in advanced solid tumors: a meta-analysis of randomized clinical trials

by Carretero-González, Alberto, Lora, David, Ghanem, Ismael, Zugazagoitia, Jon, Castellano, Daniel, Sepúlveda, Juan M., López-Martin, José A., Paz-Ares, Luis, de Velasco, Guillermo
Published in Oncotarget (2018)

The Value of PD-L1 Expression as Predictive Biomarker in Metastatic Renal Cell Carcinoma Patients: A Meta-Analysis of Randomized Clinical Trials

by Carretero-González, Alberto, Lora, David, Martín Sobrino, Isabel, Sáez Sanz, Irene, Bourlon, María T., Anido Herranz, Urbano, Martínez Chanzá, Nieves, Castellano, Daniel, de Velasco, Guillermo
Published in Cancers (Basel) (2020)

Meta-analysis on the association of VEGFR1 genetic variants with sunitinib outcome in metastatic renal cell carcinoma patients

by Liu, Xiaoyan, Swen, Jesse J., Boven, Epie, Castellano, Daniel, Gelderblom, Hans, Mathijssen, Ron H.J., Rodríguez-Antona, Cristina, García-Donas, Jesus, Rini, Brian I., Guchelaar, Henk-Jan
Published in Oncotarget (2016)

Phase II Study of Everolimus and Octreotide LAR in Patients with Nonfunctioning Gastrointestinal Neuroendocrine Tumors: The GETNE1003_EVERLAR Study

by Capdevila, Jaume, Teulé, Alexandre, Barriuso, Jorge, Castellano, Daniel, Lopez, Carlos, Manzano, Jose Luis, Alonso, Vicente, García‐Carbonero, Rocío, Dotor, Emma, Matos, Ignacio, Custodio, Ana, Casanovas, Oriol, Salazar, Ramon
Published in Oncologist (2018)

A case series of advanced renal cell carcinoma patients treated with neoadjuvant cabozantinib prior to cytoreductive nephrectomy within the phase 2 CABOPRE trial

by de Velasco, Guillermo, Carril-Ajuria, Lucia, Guerrero-Ramos, Felix, Alonso-Gordoa, Teresa, Rodríguez-Moreno, Juan F., Carretero, Alberto, Martin-Soberon, Maricruz, de la Rosa-Kehrmann, Federico, Castellano, Daniel
Published in Oncotarget (2020)

Association of single nucleotide polymorphisms in IL8 and IL13 with sunitinib-induced toxicity in patients with metastatic renal cell carcinoma

by Diekstra, Meta H. M., Liu, Xiaoyan, Swen, Jesse J., Boven, Epie, Castellano, Daniel, Gelderblom, Hans, Mathijssen, Ron H. J., Rodríguez-Antona, Cristina, García-Donas, Jesus, Rini, Brian I., Guchelaar, Henk-Jan
Published in Eur J Clin Pharmacol (2015)

Antiproliferative effects of lanreotide autogel in patients with progressive, well-differentiated neuroendocrine tumours: a Spanish, multicentre, open-label, single arm phase II st...

by Martín-Richard, Marta, Massutí, Bartomeu, Pineda, Eva, Alonso, Vicente, Marmol, Maribel, Castellano, Daniel, Fonseca, Emilio, Galán, Antonio, Llanos, Marta, Sala, Maria Angeles, Pericay, Carlos, Rivera, Fernando, Sastre, Javier, Segura, Ángel, Quindós, Maria, Maisonobe, Pascal
Published 2013

Impact of adverse events, treatment modifications, and dose intensity on survival among patients with advanced renal cell carcinoma treated with first-line sunitinib: a medical cha...

by Porta, Camillo, Levy, Antonin, Hawkins, Robert, Castellano, Daniel, Bellmunt, Joaquim, Nathan, Paul, McDermott, Ray, Wagstaff, John, Donnellan, Paul, McCaffrey, John, Vekeman, Francis, Neary, Maureen P, Diaz, Jose, Mehmud, Faisal, Duh, Mei Sheng
Published in Cancer Med (2014)

Immunohistochemistry-Based Taxonomical Classification of Bladder Cancer Predicts Response to Neoadjuvant Chemotherapy

by Font, Albert, Domènech, Montserrat, Benítez, Raquel, Rava, Marta, Marqués, Miriam, Ramírez, José L., Pineda, Silvia, Domínguez-Rodríguez, Sara, Gago, José L., Badal, Josep, Carrato, Cristina, López, Héctor, Quer, Ariadna, Castellano, Daniel, Malats, Núria, Real, Francisco X.
Published in Cancers (Basel) (2020)

Opposing roles of PIK3CA gene alterations to EZH2 signaling in non-muscle invasive bladder cancer

by Segovia, Cristina, Martínez-Fernández, Mónica, Dueñas, Marta, Rubio, Carolina, López-Calderón, Fernando F., Costa, Clotilde, Saiz-Ladera, Cristina, Fernández-Grajera, María, Duarte, José, García Muñoz, Huberto, de la Rosa, Federico, Villacampa, Felipe, Castellano, Daniel, Paramio, Jesús M.
Published in Oncotarget (2017)